Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia

Gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) represent a rare and heterogenous tumor entity. Importantly, the highly proliferative subgroup of neuroendocrine carcinoma (GEP-NEC) is characterized by high resistance to conventional chemotherapy. Consequently, there is an urgent need to id...

Descripción completa

Detalles Bibliográficos
Autores principales: Dizdar, Levent, Oesterwind, Kira A., Riemer, Jasmin C., Werner, Thomas A., Mersch, Sabrina, Möhlendick, Birte, Schütte, Sina C., Verde, Pablo E., Raba, Katharina, Topp, Stefan A., Stoecklein, Nikolas H., Esposito, Irene, Knoefel, Wolfram T., Krieg, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352407/
https://www.ncbi.nlm.nih.gov/pubmed/28039474
http://dx.doi.org/10.18632/oncotarget.14207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352407/
https://www.ncbi.nlm.nih.gov/pubmed/28039474
http://dx.doi.org/10.18632/oncotarget.14207

Ejemplares similares